CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-05 | Shawver Laura Chief Executive Officer | Exercise or conversion | +78,740 | $1.27 | $100K | 254,242 |
| 2022-08-05 | Shawver Laura Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −78,740 | 402,997 | ||
| 2022-06-10 | Thompson Peter A. Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | ROOT JONATHAN D Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | Koehler Maria Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | Islam Saqib Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | HERSHBERG ROBERT Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-06-10 | CAPPS VICKIE L Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-02 | Shawver Laura Chief Executive Officer | Grant or award | +68,107 | 175,502 | ||
| 2022-05-02 | Shawver Laura Chief Executive Officer | Grant or award · Stock Option (right to buy) | +136,214 | 136,214 | ||
| 2022-05-02 | Piazza Jonathan Chief Financial Officer | Grant or award | +43,691 | 69,225 | ||
| 2022-05-02 | Piazza Jonathan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +87,383 | 87,383 | ||
| 2022-05-02 | Odegard Valerie President and CSO | Grant or award | +45,233 | 61,639 | ||
| 2022-05-02 | Odegard Valerie President and CSO | Grant or award · Stock Option (right to buy) | +90,467 | 90,467 | ||
| 2022-05-02 | Hunder Naomi Chief Medical Officer | Grant or award | +43,177 | 54,427 | ||
| 2022-05-02 | Hunder Naomi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +86,355 | 86,355 | ||
| 2022-05-02 | Hawkinson Russ Sr. Vice President of Finance | Grant or award | +28,335 | 37,251 | ||
| 2022-05-02 | Hawkinson Russ Sr. Vice President of Finance | Grant or award · Stock Option (right to buy) | +56,670 | 56,670 | ||
| 2022-02-01 | Hawkinson Russ Sr. Vice President of Finance | Grant or award | +7,500 | 8,954 |
Page 26 of 31 · 602 trades